Preexposure Prophylaxis for Prevention of HIV Acquisition Among Adolescents: Clinical Considerations, 2020

Preexposure prophylaxis (PrEP) with antiretroviral medication has been proven effective in reducing the risk for acquiring human immunodeficiency virus (HIV). The fixed-dose combination tablet of tenofovir disoproxil fumarate (TDF)/emtricitabine (FTC) was approved by the U.S. Food and Drug Administr...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanner, Mary R., Miele, Peter, Carter, Wendy, Valentine, Sheila Salvant, Dunville, Richard, Kapogiannis, Bill G., Smith, Dawn K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2020
Materias:
Recommendations and Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188407/
https://www.ncbi.nlm.nih.gov/pubmed/32324724
http://dx.doi.org/10.15585/mmwr.rr6903a1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188407/
https://www.ncbi.nlm.nih.gov/pubmed/32324724
http://dx.doi.org/10.15585/mmwr.rr6903a1

Ejemplares similares